Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)

• The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway.

Gespeichert in:

Autor*in:	Florentino, Iziara F. [verfasserIn] Galdino, Pablinny M. De Oliveira, Lanussy P. Silva, Daiany P.B. Pazini, Francine Vanderlinde, Frederico A. Lião, Luciano M. Menegatti, Ricardo Costa, Elson A.

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2015

Umfang:	8

Übergeordnetes Werk:	Enthalten in: Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways - Gao, Ying ELSEVIER, 2013, biology and chemistry : the official journal of the Nitric Oxide Society, Orlando, Fla
Übergeordnetes Werk:	volume:47 ; year:2015 ; day:1 ; month:05 ; pages:17-24 ; extent:8

Links:	Volltext

DOI / URN:	10.1016/j.niox.2015.02.146

Katalog-ID:	ELV034772219

Internformat


LEADER	01000caa a22002652 4500
001	ELV034772219
003	DE-627
005	20230624015154.0
007	cr uuu---uuuuu
008	180603s2015 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/j.niox.2015.02.146 \|2 doi
028	5	2	\|a GBVA2015018000024.pica
035			\|a (DE-627)ELV034772219
035			\|a (ELSEVIER)S1089-8603(15)00174-3
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0		\|a 570 \|a 540
082	0	4	\|a 570 \|q DE-600
082	0	4	\|a 540 \|q DE-600
082	0	4	\|a 570 \|q VZ
082	0	4	\|a 670 \|q VZ
084			\|a 51.60 \|2 bkl
084			\|a 58.45 \|2 bkl
100	1		\|a Florentino, Iziara F. \|e verfasserin \|4 aut
245	1	0	\|a Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)
264		1	\|c 2015
300			\|a 8
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a nicht spezifiziert \|b z \|2 rdamedia
338			\|a nicht spezifiziert \|b zu \|2 rdacarrier
520			\|a • The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway.
700	1		\|a Galdino, Pablinny M. \|4 oth
700	1		\|a De Oliveira, Lanussy P. \|4 oth
700	1		\|a Silva, Daiany P.B. \|4 oth
700	1		\|a Pazini, Francine \|4 oth
700	1		\|a Vanderlinde, Frederico A. \|4 oth
700	1		\|a Lião, Luciano M. \|4 oth
700	1		\|a Menegatti, Ricardo \|4 oth
700	1		\|a Costa, Elson A. \|4 oth
773	0	8	\|i Enthalten in \|n Acad. Press \|a Gao, Ying ELSEVIER \|t Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways \|d 2013 \|d biology and chemistry : the official journal of the Nitric Oxide Society \|g Orlando, Fla \|w (DE-627)ELV017091187
773	1	8	\|g volume:47 \|g year:2015 \|g day:1 \|g month:05 \|g pages:17-24 \|g extent:8
856	4	0	\|u https://doi.org/10.1016/j.niox.2015.02.146 \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
936	b	k	\|a 51.60 \|j Keramische Werkstoffe \|j Hartstoffe \|x Werkstoffkunde \|q VZ
936	b	k	\|a 58.45 \|j Gesteinshüttenkunde \|q VZ
951			\|a AR
952			\|d 47 \|j 2015 \|b 1 \|c 0501 \|h 17-24 \|g 8
953			\|2 045F \|a 570

Indexfelder

author_variant	i f f if iff
matchkey_str	florentinoiziarafgaldinopablinnymdeolive:2015----:novmnoteogpapahaitenioietvefcoteeprzl53loohnl
hierarchy_sort_str	2015
bklnumber	51.60 58.45
publishDate	2015
allfields	10.1016/j.niox.2015.02.146 doi GBVA2015018000024.pica (DE-627)ELV034772219 (ELSEVIER)S1089-8603(15)00174-3 DE-627 ger DE-627 rakwb eng 570 540 570 DE-600 540 DE-600 570 VZ 670 VZ 51.60 bkl 58.45 bkl Florentino, Iziara F. verfasserin aut Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021) 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway. Galdino, Pablinny M. oth De Oliveira, Lanussy P. oth Silva, Daiany P.B. oth Pazini, Francine oth Vanderlinde, Frederico A. oth Lião, Luciano M. oth Menegatti, Ricardo oth Costa, Elson A. oth Enthalten in Acad. Press Gao, Ying ELSEVIER Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways 2013 biology and chemistry : the official journal of the Nitric Oxide Society Orlando, Fla (DE-627)ELV017091187 volume:47 year:2015 day:1 month:05 pages:17-24 extent:8 https://doi.org/10.1016/j.niox.2015.02.146 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.60 Keramische Werkstoffe Hartstoffe Werkstoffkunde VZ 58.45 Gesteinshüttenkunde VZ AR 47 2015 1 0501 17-24 8 045F 570
spelling	10.1016/j.niox.2015.02.146 doi GBVA2015018000024.pica (DE-627)ELV034772219 (ELSEVIER)S1089-8603(15)00174-3 DE-627 ger DE-627 rakwb eng 570 540 570 DE-600 540 DE-600 570 VZ 670 VZ 51.60 bkl 58.45 bkl Florentino, Iziara F. verfasserin aut Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021) 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway. Galdino, Pablinny M. oth De Oliveira, Lanussy P. oth Silva, Daiany P.B. oth Pazini, Francine oth Vanderlinde, Frederico A. oth Lião, Luciano M. oth Menegatti, Ricardo oth Costa, Elson A. oth Enthalten in Acad. Press Gao, Ying ELSEVIER Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways 2013 biology and chemistry : the official journal of the Nitric Oxide Society Orlando, Fla (DE-627)ELV017091187 volume:47 year:2015 day:1 month:05 pages:17-24 extent:8 https://doi.org/10.1016/j.niox.2015.02.146 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.60 Keramische Werkstoffe Hartstoffe Werkstoffkunde VZ 58.45 Gesteinshüttenkunde VZ AR 47 2015 1 0501 17-24 8 045F 570
allfields_unstemmed	10.1016/j.niox.2015.02.146 doi GBVA2015018000024.pica (DE-627)ELV034772219 (ELSEVIER)S1089-8603(15)00174-3 DE-627 ger DE-627 rakwb eng 570 540 570 DE-600 540 DE-600 570 VZ 670 VZ 51.60 bkl 58.45 bkl Florentino, Iziara F. verfasserin aut Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021) 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway. Galdino, Pablinny M. oth De Oliveira, Lanussy P. oth Silva, Daiany P.B. oth Pazini, Francine oth Vanderlinde, Frederico A. oth Lião, Luciano M. oth Menegatti, Ricardo oth Costa, Elson A. oth Enthalten in Acad. Press Gao, Ying ELSEVIER Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways 2013 biology and chemistry : the official journal of the Nitric Oxide Society Orlando, Fla (DE-627)ELV017091187 volume:47 year:2015 day:1 month:05 pages:17-24 extent:8 https://doi.org/10.1016/j.niox.2015.02.146 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.60 Keramische Werkstoffe Hartstoffe Werkstoffkunde VZ 58.45 Gesteinshüttenkunde VZ AR 47 2015 1 0501 17-24 8 045F 570
allfieldsGer	10.1016/j.niox.2015.02.146 doi GBVA2015018000024.pica (DE-627)ELV034772219 (ELSEVIER)S1089-8603(15)00174-3 DE-627 ger DE-627 rakwb eng 570 540 570 DE-600 540 DE-600 570 VZ 670 VZ 51.60 bkl 58.45 bkl Florentino, Iziara F. verfasserin aut Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021) 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway. Galdino, Pablinny M. oth De Oliveira, Lanussy P. oth Silva, Daiany P.B. oth Pazini, Francine oth Vanderlinde, Frederico A. oth Lião, Luciano M. oth Menegatti, Ricardo oth Costa, Elson A. oth Enthalten in Acad. Press Gao, Ying ELSEVIER Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways 2013 biology and chemistry : the official journal of the Nitric Oxide Society Orlando, Fla (DE-627)ELV017091187 volume:47 year:2015 day:1 month:05 pages:17-24 extent:8 https://doi.org/10.1016/j.niox.2015.02.146 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.60 Keramische Werkstoffe Hartstoffe Werkstoffkunde VZ 58.45 Gesteinshüttenkunde VZ AR 47 2015 1 0501 17-24 8 045F 570
allfieldsSound	10.1016/j.niox.2015.02.146 doi GBVA2015018000024.pica (DE-627)ELV034772219 (ELSEVIER)S1089-8603(15)00174-3 DE-627 ger DE-627 rakwb eng 570 540 570 DE-600 540 DE-600 570 VZ 670 VZ 51.60 bkl 58.45 bkl Florentino, Iziara F. verfasserin aut Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021) 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway. Galdino, Pablinny M. oth De Oliveira, Lanussy P. oth Silva, Daiany P.B. oth Pazini, Francine oth Vanderlinde, Frederico A. oth Lião, Luciano M. oth Menegatti, Ricardo oth Costa, Elson A. oth Enthalten in Acad. Press Gao, Ying ELSEVIER Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways 2013 biology and chemistry : the official journal of the Nitric Oxide Society Orlando, Fla (DE-627)ELV017091187 volume:47 year:2015 day:1 month:05 pages:17-24 extent:8 https://doi.org/10.1016/j.niox.2015.02.146 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.60 Keramische Werkstoffe Hartstoffe Werkstoffkunde VZ 58.45 Gesteinshüttenkunde VZ AR 47 2015 1 0501 17-24 8 045F 570
language	English
source	Enthalten in Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways Orlando, Fla volume:47 year:2015 day:1 month:05 pages:17-24 extent:8
sourceStr	Enthalten in Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways Orlando, Fla volume:47 year:2015 day:1 month:05 pages:17-24 extent:8
format_phy_str_mv	Article
bklname	Keramische Werkstoffe Hartstoffe Gesteinshüttenkunde
institution	findex.gbv.de
dewey-raw	570
isfreeaccess_bool	false
container_title	Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways
authorswithroles_txt_mv	Florentino, Iziara F. @@aut@@ Galdino, Pablinny M. @@oth@@ De Oliveira, Lanussy P. @@oth@@ Silva, Daiany P.B. @@oth@@ Pazini, Francine @@oth@@ Vanderlinde, Frederico A. @@oth@@ Lião, Luciano M. @@oth@@ Menegatti, Ricardo @@oth@@ Costa, Elson A. @@oth@@
publishDateDaySort_date	2015-01-01T00:00:00Z
hierarchy_top_id	ELV017091187
dewey-sort	3570
id	ELV034772219
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV034772219</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624015154.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.niox.2015.02.146</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015018000024.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV034772219</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1089-8603(15)00174-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield><subfield code="a">540</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.60</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Florentino, Iziara F.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galdino, Pablinny M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Oliveira, Lanussy P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silva, Daiany P.B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pazini, Francine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vanderlinde, Frederico A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lião, Luciano M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Menegatti, Ricardo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Costa, Elson A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Acad. Press</subfield><subfield code="a">Gao, Ying ELSEVIER</subfield><subfield code="t">Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways</subfield><subfield code="d">2013</subfield><subfield code="d">biology and chemistry : the official journal of the Nitric Oxide Society</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV017091187</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:47</subfield><subfield code="g">year:2015</subfield><subfield code="g">day:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:17-24</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.niox.2015.02.146</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.60</subfield><subfield code="j">Keramische Werkstoffe</subfield><subfield code="j">Hartstoffe</subfield><subfield code="x">Werkstoffkunde</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.45</subfield><subfield code="j">Gesteinshüttenkunde</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">47</subfield><subfield code="j">2015</subfield><subfield code="b">1</subfield><subfield code="c">0501</subfield><subfield code="h">17-24</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">570</subfield></datafield></record></collection>
author	Florentino, Iziara F.
spellingShingle	Florentino, Iziara F. ddc 570 ddc 540 ddc 670 bkl 51.60 bkl 58.45 Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)
authorStr	Florentino, Iziara F.
ppnlink_with_tag_str_mv	@@773@@(DE-627)ELV017091187
format	electronic Article
dewey-ones	570 - Life sciences; biology 540 - Chemistry & allied sciences 670 - Manufacturing
delete_txt_mv	keep
author_role	aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
topic_title	570 540 570 DE-600 540 DE-600 570 VZ 670 VZ 51.60 bkl 58.45 bkl Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)
topic	ddc 570 ddc 540 ddc 670 bkl 51.60 bkl 58.45
topic_unstemmed	ddc 570 ddc 540 ddc 670 bkl 51.60 bkl 58.45
topic_browse	ddc 570 ddc 540 ddc 670 bkl 51.60 bkl 58.45
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	zu
author2_variant	p m g pm pmg o l p d olp olpd d p s dp dps f p fp f a v fa fav l m l lm lml r m rm e a c ea eac
hierarchy_parent_title	Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways
hierarchy_parent_id	ELV017091187
dewey-tens	570 - Life sciences; biology 540 - Chemistry 670 - Manufacturing
hierarchy_top_title	Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)ELV017091187
title	Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)
ctrlnum	(DE-627)ELV034772219 (ELSEVIER)S1089-8603(15)00174-3
title_full	Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)
author_sort	Florentino, Iziara F.
journal	Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways
journalStr	Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways
lang_code	eng
isOA_bool	false
dewey-hundreds	500 - Science 600 - Technology
recordtype	marc
publishDateSort	2015
contenttype_str_mv	zzz
container_start_page	17
author_browse	Florentino, Iziara F.
container_volume	47
physical	8
class	570 540 570 DE-600 540 DE-600 570 VZ 670 VZ 51.60 bkl 58.45 bkl
format_se	Elektronische Aufsätze
author-letter	Florentino, Iziara F.
doi_str_mv	10.1016/j.niox.2015.02.146
dewey-full	570 540 670
title_sort	involvement of the no/cgmp/katp pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1h-pyrazol-4-yl)-2h-tetrazole (lqfm-021)
title_auth	Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)
abstract	• The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway.
abstractGer	• The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway.
abstract_unstemmed	• The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway.
collection_details	GBV_USEFLAG_U GBV_ELV SYSFLAG_U
title_short	Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)
url	https://doi.org/10.1016/j.niox.2015.02.146
remote_bool	true
author2	Galdino, Pablinny M. De Oliveira, Lanussy P. Silva, Daiany P.B. Pazini, Francine Vanderlinde, Frederico A. Lião, Luciano M. Menegatti, Ricardo Costa, Elson A.
author2Str	Galdino, Pablinny M. De Oliveira, Lanussy P. Silva, Daiany P.B. Pazini, Francine Vanderlinde, Frederico A. Lião, Luciano M. Menegatti, Ricardo Costa, Elson A.
ppnlink	ELV017091187
mediatype_str_mv	z
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth oth oth oth oth oth oth
doi_str	10.1016/j.niox.2015.02.146
up_date	2024-07-06T21:57:55.285Z
_version_	1803868517471092736
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV034772219</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624015154.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.niox.2015.02.146</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015018000024.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV034772219</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1089-8603(15)00174-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">570</subfield><subfield code="a">540</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.60</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Florentino, Iziara F.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The pyrasole compound LQFM 021 has peripheral antinociceptive effect. • The NO release is important for antinociceptive effect of the LQFM 021. • The antinociceptive effect of the LQFM 021 involved the NO/cGMP/KATP pathway.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Galdino, Pablinny M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Oliveira, Lanussy P.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Silva, Daiany P.B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pazini, Francine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vanderlinde, Frederico A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lião, Luciano M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Menegatti, Ricardo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Costa, Elson A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Acad. Press</subfield><subfield code="a">Gao, Ying ELSEVIER</subfield><subfield code="t">Enhancement of (−)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways</subfield><subfield code="d">2013</subfield><subfield code="d">biology and chemistry : the official journal of the Nitric Oxide Society</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV017091187</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:47</subfield><subfield code="g">year:2015</subfield><subfield code="g">day:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:17-24</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.niox.2015.02.146</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.60</subfield><subfield code="j">Keramische Werkstoffe</subfield><subfield code="j">Hartstoffe</subfield><subfield code="x">Werkstoffkunde</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.45</subfield><subfield code="j">Gesteinshüttenkunde</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">47</subfield><subfield code="j">2015</subfield><subfield code="b">1</subfield><subfield code="c">0501</subfield><subfield code="h">17-24</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">570</subfield></datafield></record></collection>
score	7.402135

Nicht das Richtige dabei?

Schreiben Sie uns!

Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?